Wide Ranks

LIVN

LivaNova PLC

52.48

Top Statistics
Market Cap 2 B Forward PE 14.48 Revenue Growth 11.20 %
Current Ratio 3.37 Trailing PE 122.05 Earnings Growth 0.00 %
Profit Margins 1.91 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 14.97 Enterprise / Revenue 2.56 Price To Sales Trailing12 Months 2.29
Profitability
Profit Margins 1.91 % Operating Margins 14.09 %
Balance Sheet
Total Cash 346 M Total Cash Per Share 6.38 Total Debt 679 M
Total Debt To Equity 51.89 Current Ratio 3.37 Book Value Per Share 24.13
All Measures
Short Ratio 469.00 % Message Board Id finmb_27283 Shares Short Prior Month 2 M
Return On Equity 0.0187 City London Uuid 061a8c8c-b203-3fe1-ac5c-dcaa64a141fe
Previous Close 50.69 First Trade Date Epoch Utc 1 B Book Value 24.13
Beta 1.01 Total Debt 679 M Volume 466338
Price To Book 2.18 Fifty Two Week Low 42.75 Total Cash Per Share 6.38
Total Revenue 1 B Shares Short Previous Month Date 1 B Target Median Price 70.00
Audit Risk 3 Max Age 86400 Recommendation Mean 1.82
Sand P52 Week Change 0.3133 Operating Margins 14.09 % Target Mean Price 69.00
Net Income To Common 23 M Short Percent Of Float 0.0577 Implied Shares Outstanding 54 M
Trailing Peg Ratio 49.68 % Last Fiscal Year End 1 B Average Daily Volume10 Day 449090
Average Volume10days 449090 Total Cash 346 M Next Fiscal Year End 1 B
Revenue Per Share 22.91 Held Percent Insiders 0.0033 Ebitda Margins 17.12 %
Trailing PE 122.05 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 3 Regular Market Previous Close 50.69 Target Low Price 53.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 52.21 Open 50.57
Free Cashflow 124 M Dividend Yield 0.00 % Return On Assets 0.0434
Time Zone Short Name EST Board Risk 1 Trailing Eps 0.4300
Day Low 50.57 Address1 20 Eastbourne Terrace Shares Outstanding 54 M
Compensation Risk 3 Price Hint 2 Target High Price 90.00
Website https://www.livanova.com 52 Week Change 0.1701 Average Volume 468665
Forward Eps 3.70 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 167.50 % Is_sp_500 False Regular Market Day High 52.66
Profit Margins 1.91 % Debt To Equity 51.89 Fifty Two Week High 64.47
Day High 52.66 Shares Short 2 M Regular Market Open 50.57
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 2.56
Revenue Growth 11.20 % Shares Percent Shares Out 0.0435 Operating Cashflow 158 M
Currency USD Time Zone Full Name America/New_York Market Cap 2 B
Is_nasdaq_100 False Zip W2 6LG Quote Type EQUITY
Industry Medical Devices Long Name LivaNova PLC Overall Risk 2
Regular Market Day Low 50.57 Held Percent Institutions 1.01 Current Price 52.48
Enterprise To Ebitda 14.97 Financial Currency USD Current Ratio 3.37
Gross Margins 68.09 % Industry Disp Medical Devices Number Of Analyst Opinions 11
Country United Kingdom Float Shares 51 M Two Hundred Day Average 53.13
Governance Epoch Date 1 B Enterprise Value 3 B Price To Sales Trailing12 Months 2.29
Forward PE 14.48 Regular Market Volume 466338 Ebitda 212 M
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide.

The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments.

The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices.

The Advanced Circulatory Support segment develops, produces, and sells temporary life support products.

It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers.

The company sells its products through direct sales representatives and independent distributors.

LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.